REVIEWS

• Serious Adverse Events in Hematopoietic Stem Cell Donors: A Literature Review

  Elena Vitalevna Kuzmich, I.E. Pavlova, T.V. Glazanova, L.N. Bubnova

  327-334

  01.07.2026

• Effect of Bruton Tyrosine Kinase Inhibitors on T-Lymphocytes and Tumor Microenvironment Cells in B-Cell Lymphoproliferative Diseases

  Yuliya Sergeevna Efremova, T.V. Glazanova, N.A. Romanenko

  320-326

  01.07.2026

• Diagnostic Value of Platelet Transcriptome in Myeloproliferative Neoplasms

  I.A. Olkhovskiy, M.A. Stolyar, A.S. Gorbenko

  131-141

  01.04.2026

• Autophagy: cell death or survival strategy?

  O.V. Kovaleva, M.S. Shitova, I.B. Zborovskaya

  103-113

  01.07.2025

• Functional Cure as a New Concept of Therapy for Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  105-120

  01.04.2025

• Chronic Lymphocytic Leukemia: A Genomic Landscape and Cellular Signal Pathways

  M.A. Mikhaleva, Evgenii Olegovich Kunevich, A.Yu. Kuvshinov, S.V. Voloshin

  21-37

  01.01.2025

• The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review

  Elena Andreevna Kuzmina, E.Yu. Chelysheva, B.V. Biderman, A.G. Turkina

  10-20

  01.01.2025

• Cardiovascular Toxicity of CAR-T Cell Therapy: A Literature Review

  Shakhabutdin Murtuzalievich Murtuzaliev, E.Yu. Salakheeva, S.A. Kardovskaya, Yu.Yu. Kirichenko, E.A. Siderko, Yu.N. Belenkov, I.S. Ilgisonis

  404-414

  01.10.2024

• The Value of Combined PET/CT in Diffuse Large B-Cell Lymphoma: Historical Background, Evolution of Views, and Current Opportunities of the Method (Literature Review)

  Artem Andreevich Vovchenko, N.A. Falaleeva, A.A. Danilenko, A.Yu. Terekhova, M.M. Khodzhibekova, A.M. Chelmakov, A.G. Zamotina, A.S. Dikova, S.V. Ruchkova, Yu.V. Sinitsyna, V.Yu. Kovalskaya, A.N. Perepelitsyna, A.N. Balashova, D.A. Manaenkov, S.A. Ivanov

  66-75

  17.05.2024

• Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View

  Sergei Vyacheslavovich Semochkin

  94-108

  01.04.2024

• Plasmablastic Lymphoma and Plasmablastic Myeloma: А Diagnostic Dilemma (Literature Review)

  Mariya Vladimirovna Melnikova, A.M. Kovrigina

  129-140

  01.04.2024

• PET/CT in Hematological Malignancies: What Has Been Achieved and What Remains to Be Done

  Aleksei Sergeevich Subbotin, A.I. Pronin, T.M. Geliashvili, P.E. Tulin, T.S. Basova, B.M. Khakulova, G.S. Tumyan, A.A. Semenova

  109-128

  01.04.2024

• Historical Background of the Role of Bone Marrow Core Biopsy in the Staging System for Classical Hodgkin Lymphoma and the Current View in the Era of PET-CT: A Literature Review

  Anatolii Aleksandrovich Danilenko, N.A. Falaleeva, S.V. Shakhtarina

  351-360

  28.09.2023

• The Role of Leukocytes in the Formation of Neutrophil Extracellular Traps and Thrombosis in Ph-Negative Myeloproliferative Neoplasms: A Literature Review

  Boldukyz Tolgonbaevna Dzhumabaeva

  263-267

  09.06.2023

• Classical Hodgkin Lymphoma: Tumor Structure and Prognostic Value of the Immune Microenvironment

  Artem Aleksandrovich Gusak, K.V. Lepik, L.V. Fedorova, V.V. Markelov, V.V. Baykov

  242-262

  09.06.2023

• Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  229-241

  09.06.2023

• KIR-Genetic Factors and Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

  Elena Vital’evna Kuzmich, I.E. Pavlova, L.N. Bubnova, S.S. Bessmeltsev

  119-127

  03.03.2023

• Morpho-Immunohistochemical Characteristics of Different Mycosis Fungoides Stages: A Literature Review

  Andrei Alekseevich Sherstnev, A.M. Kovrigina

  109-118

  03.03.2023

• Combination of Ibrutinib and Venetoclax in the Therapy of Chronic Lymphocytic Leukemia: A Review of the Latest Data from Clinical Studies

  A.A. Petrenko, Mariya Igorevna Kislova, E.A. Dmitrieva, E.A. Nikitin, V.V. Ptushkin

  37-45

  01.01.2023

• Prognostic Models in Medicine

  Aleksander Sergeevich Luchinin

  27-36

  01.01.2023